Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Karen S Lynch is Director at Thermo Fisher Scientific. OQRO lists 6 transactions filed with the SEC under this name, the latest on Nov 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
6
Companies involved
2
As of the latest filing on , Karen S Lynch reported holding 2,759 shares of Automatic Data Processing (ADP), worth about $843K at the last close of $306 (Nov 18, 2026). Holdings are also on file at Thermo Fisher Scientific (TMO); together they are worth about $1.65M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Automatic Data Processing ADP | 2,759 | 2,759 direct | $306 | $843K | Nov 11, 2026 |
| Thermo Fisher Scientific TMO | 1,159 | 1,159 direct | $693 | $803K | May 20, 2026 |
Is this Karen S Lynch’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Karen S Lynch reported 1 open-market purchase and 1 sale here, 2019 to 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Nov 11, 20261,224disclosed Nov 12
DetailsOfficial recordThermo Fisher ScientificTMO
5 disclosures · Jan 2026 – Sep 2026
Sep 26, 202646.3disclosed Sep 29
DetailsOfficial recordJun 27, 202660.91disclosed Jun 30
DetailsOfficial recordMay 20, 2026499disclosed May 22
DetailsOfficial recordMar 28, 202666.02disclosed Mar 31
DetailsOfficial recordDec 31, 202553.93disclosed Jan 5
DetailsOfficial recordKaren S Lynch bought shares on the open market in 2023, and has not bought since 2023. Sales in 1 of the 8 years since 2019.
Karen S Lynch reported 1 open-market purchase and 1 sale since 2019; purchases in 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $977K1×1 trade | — |
| 2019 | — | $6.01M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 11, 2026, Karen S Lynch reported holding 2,759 shares of Automatic Data Processing (ADP). At the last close of $306 on Nov 18, 2026, that is about $843K. This is the stake disclosed in filings, not a net worth.
No public filing gives Karen S Lynch's net worth. What SEC Form 4 shows is the stock stake: 2,759 shares of Automatic Data Processing (ADP), about $843K at the last close, plus holdings in 1 other company, about $1.65M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Karen S Lynch bought shares on the open market in 2023, and has not bought since 2023. Sales in 1 of the 8 years since 2019.
In SEC filings since 2019: the latest open-market purchase is from 2023; the latest open-market sale is from 2019.
CVS Health (CVS), from 2019 to 2023: 1 purchase and 1 sale.